The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127358561 12735856 1 I 20160725 20160913 20160913 PER US-JNJFOC-20160721997 JANSSEN 0.00 E F Y 49.90000 KG 20160913 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127358561 12735856 1 PS IMODIUM A-D LOPERAMIDE HYDROCHLORIDE 1 Oral U U 5DE1702;0045-0295-32 19860 CAPLET
127358561 12735856 2 SS IMODIUM A-D LOPERAMIDE HYDROCHLORIDE 1 Oral 1-2 CAPLETS PER ISSUE OF IBSWITH ONE THEN ONE; NO MORE THAN 4 IN 24 HRS. STARTED ON 24-JUL U U 5DE1702;0045-0295-32 19860 CAPLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127358561 12735856 2 Irritable bowel syndrome

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
127358561 12735856 Product packaging issue
127358561 12735856 Unintentional use for unapproved indication

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found